Clinical Trial Study
Investigating the Link between Type 2 Diabetes, Obesity, and Cardiovascular Risk
Wellness Clinical Research is looking for participants for a Type 2 Diabetes and Obesity study in Vega Baja, Puerto Rico.
Type 2 diabetes is a health condition in which the body fails to use insulin properly - a hormone that helps convert sugar into energy. It may occur due to genetics, a sedentary lifestyle, or obesity. When insulin is not utilized effectively, sugar accumulates in the bloodstream, resulting in various health complications. Symptoms of type 2 diabetes include fatigue, frequent thirst, and increased urination.
If you're 18 years or older and have been diagnosed with type 2 diabetes, you may qualify for a research study assessing the effectiveness and safety of Orforglipron in comparison to insulin glargine. The study is specifically targeting individuals with type 2 diabetes, obesity or overweight, and an increased risk of cardiovascular diseases.
No health insurance required
Benefits of Participation:
You may receive compensation for your time and travel expenses.
All study care, procedures, and medications at no cost to you.
Gain access to a new investigate Type 2 Diabetes and Obesity or Overweight at increased cardiovascular risk treatment that is not yet available to the public.
Register Now
Our research coordinator will contact you to verify your eligibility and answer any questions you may have.
By clicking Submit, you agree to the Study Catalyst Privacy Policy, and Terms of Service.